A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013).Juanita Crook, Laurence Klotz, Chris J. O’Callaghan et al.|Journal of Clinical Oncology|2011Cited by 51